-
Mashup Score: 2International Lung Cancer Congress - 6 month(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2Dr Hirsch on the Treatment of NRG1 Fusion+ NSCLC - 6 month(s) ago
Fred R. Hirsch, MD, PhD, discusses the activity of HER3-directed agents in patients with non–small cell lung cancer harboring NRG1 mutations.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
WATCH: @fred_hirsch, of @TischCancer and @IcahnMountSinai, discusses the activity of HER3-directed agents in patients with non–small cell lung cancer harboring NRG1 mutations. @gotoPER #gotoPER #LCSM https://t.co/xk422GZSo9
-
-
Mashup Score: 2International Lung Cancer Congress - 6 month(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Thank you to @ErminiaMassare1, of @cityofhope, for stopping by during ILCC to discuss RET and NTRK fusions in NSCLC! Head to our site for exclusive conference updates! @gotoPER #gotoPER #lcsm https://t.co/QhL7uG8oWe https://t.co/JOyzVt7P8l
-
-
Mashup Score: 2International Lung Cancer Congress - 6 month(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Thank you to @ErminiaMassare1, of @cityofhope, for stopping by during ILCC to discuss RET and NTRK fusions in NSCLC! Head to our site for exclusive conference updates! @gotoPER #gotoPER #lcsm https://t.co/QhL7uG8oWe https://t.co/JOyzVt7P8l
-
-
Mashup Score: 2International Lung Cancer Congress - 6 month(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Thank you to @ErminiaMassare1, of @cityofhope, for stopping by during ILCC to discuss RET and NTRK fusions in NSCLC! Head to our site for exclusive conference updates! @gotoPER #gotoPER #lcsm https://t.co/QhL7uG8oWe https://t.co/JOyzVt7P8l
-
-
Mashup Score: 2International Lung Cancer Congress - 6 month(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Thank you to @ErminiaMassare1, of @cityofhope, for stopping by during ILCC to discuss RET and NTRK fusions in NSCLC! Head to our site for exclusive conference updates! @gotoPER #gotoPER #lcsm https://t.co/QhL7uG8oWe https://t.co/JOyzVt7P8l
-
-
Mashup Score: 2Dr Sabari on Barriers to Biomarker Testing in NSCLC - 6 month(s) ago
Joshua K. Sabari, MD, discusses barriers to biomarker testing in patients with non–small cell lung cancer.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
WATCH: @JSabari, of @Perlmutter_CC, discusses barriers to biomarker testing in patients with non–small cell lung cancer. @gotoPER #gotoPER #lcsm https://t.co/XVQ5QRQMVf
-
-
Mashup Score: 2
Julia Rotow, MD, discusses the importance of comprehensive biomarker testing for all patients with NSCLC.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
WATCH: @JuliaRotow, of @DanaFarber and @harvardmed, discusses the importance of comprehensive biomarker testing for all patients with NSCLC. @gotoPER #gotoPER #lcsm https://t.co/8aWJ6KjXvt
-
-
Mashup Score: 3
Roy S. Herbst, MD, PhD, discusses the importance of consulting a multidisciplinary tumor board when making treatment decisions for patients with NSCLC.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
.@DrRoyHerbstYale, of @YaleMed, discusses the importance of multidisciplinary tumor boards for making NSCLC treatment decisions, as well as the optimal treatment course for patients with stage III, EGFR-mutated disease. @gotoper #gotoPER #lcsm https://t.co/qR0Fv0xFj4
-
-
Mashup Score: 10Dr Backhus on Surgical Eligibility in Borderline Resectable NSCLC - 6 month(s) ago
Leah Backhus, MD, MPH, FACS, discusses the evolving definition of surgical resectability in patients with borderline resectable NSCLC.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
.@leahbackhusmd, of @StanfordMed, discusses the evolving definition of surgical resectability in patients with borderline resectable NSCLC. @gotoper #gotoPER #LCSM https://t.co/sn9VYTPnTu
-
Thank you to @ErminiaMassare1, of @cityofhope, for stopping by during ILCC to discuss RET and NTRK fusions in NSCLC! Head to our site for exclusive conference updates! @gotoPER #gotoPER #lcsm https://t.co/QhL7uG8oWe https://t.co/JOyzVt7P8l